Managers / Q4 2019 · view latest →
BENNICAS & ASSOCIATES, INC.
CIK 0001056821 · 838 PORTOLA ROAD, PORTOLA VALLEY, CA, 94028 · 6508514601
Summary
Bennicas & Associates, Inc. reported $138M in U.S.-listed holdings across 85 positions for Q4 2019.
Its largest position, PG, represents 13.8% of the portfolio.
Compared with Q3 2019, the fund opened 5 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 75.7% · $105M
- Other · 13.0% · $18M
- REIT · 5.9% · $8M
- ADR · 3.8% · $5M
- Closed-End Fund · 1.4% · $2M
- ETP · 0.2% · $282,000
Quarter-over-Quarter Changes full breakdown →
vs Q3 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| OXYOccidental Petroleum | NEW | +39.3K | 39.3K | +$2M | $2M |
| DOCHealthpeak Properties Inc (frm | NEW | +23.1K | 23.1K | +$795,000 | $795,000 |
| SLBSchlumberger, Ltd. | NEW | +16.2K | 16.2K | +$651,000 | $651,000 |
| NGNovaGold Resources Inc. | NEW | +30.9K | 30.9K | +$277,000 | $277,000 |
| AngloGold Ashanti Ltd. | NEW | +9.4K | 9.4K | +$210,000 | $210,000 |
| PFEPfizer Inc. | ADDED | +31.7K | 53.7K | +$1M | $2M |
| TTENTotal S.A. ADR | ADDED | +23.7K | 46.1K | +$1M | $3M |
| HCP, Inc. | SOLD OUT | −23.1K | 0 | −$822,000 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2023 | Under review | 99 | Mar 1, 2023 | RESTATEMENT | changes · EDGAR ↗ |
| Q4 2022 | Under review | 99 | Jan 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $157M | 98 | Oct 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $171M | 101 | Jul 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $199M | 106 | Apr 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $192M | 101 | Jan 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $178M | 99 | Oct 8, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $182M | 99 | Jul 9, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $174M | 99 | Apr 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $172M | 99 | Jan 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $161M | 94 | Oct 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $133M | 82 | Jul 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $113M | 78 | Apr 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $138M | 85 | Jan 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $129M | 83 | Oct 7, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $120M | 83 | Jul 12, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $114M | 82 | Apr 16, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $109M | 87 | Jan 18, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.